Optogenetics: The Nobel-Winning Breakthrough and Its Implications in Biotechnology

Abstract

The 2026 Nobel Prize in Physiology or Medicine celebrated the breakthroughs in optogenetics, the methodology combining genetic targeting and optical control to monitor and manipulate cellular activity. This Editorial will summarize the rise of optogenetics and its transformative impact on neuroscience and discuss its role as an expanding force across clinical and biotechnological domains, with a focus on translational and industrial prospects.